Who
Medina Manuel Hidalgo
Director
Company insider
Files Form 4 as: Director, Guardant Health; Director, Bristol-Myers Squibb.
In numbers
- Trades disclosed
- 110
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.7M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Jun 2021
- Last trade
- 17 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Oct 2026filed 19 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Oct 2026filed 19 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $31K950 at $32.55 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $156K950 at $163.95 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $123K750 at $164.61 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —950 at $0.00 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —950 at $0.00 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $31K950 at $32.55 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $156K950 at $163.95 | filing |
| 5 Aug 2026filed 6 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $123K750 at $164.61 | filing |
| 17 Jul 2026filed 20 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —232 at $0.00 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Contrasting BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH)GH · tickerreport.com · 21 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026
0 headlines in the last 90 days name Medina Manuel Hidalgo; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.